BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 25747927)

  • 1. The globalization of addiction research: capacity-building mechanisms and selected examples.
    Rawson RA; Woody G; Kresina TF; Gust S
    Harv Rev Psychiatry; 2015; 23(2):147-56. PubMed ID: 25747927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing evidence-based substance use interventions globally: The National Institute on Drug Abuse postdoctoral fellowships.
    Gust SW; McCormally J; Park NH
    Subst Abus; 2021; 42(4):397-406. PubMed ID: 34597258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reflecting on 30 years of research. A look at how NIDA has advanced the research, prevention, and treatment of drug abuse and addiction.
    Condon TP
    Behav Healthc; 2006 May; 26(5):14, 16. PubMed ID: 16736912
    [No Abstract]   [Full Text] [Related]  

  • 4. Should the reorganization of addiction-related research across all the National Institutes of Health be structural?--The devil is truly in the details.
    Johnson BA; Messing RO; Charness ME; Crabbe JC; Goldman MS; Harris RA; Kranzler HR; Mitchell MC; Nixon SJ; Riley EP; Schuckit MA; Sher KJ; Thomas JD
    Alcohol Clin Exp Res; 2011 Apr; 35(4):572-80. PubMed ID: 21443646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs and Addiction Science: NIDA Celebrates 50 Years of Research and Looks to the Future.
    Volkow ND
    Am J Psychiatry; 2024 May; 181(5):349-352. PubMed ID: 38706329
    [No Abstract]   [Full Text] [Related]  

  • 6. PERSPECTIVE: Health Economic Interests at NIMH and NIDA to Improve Delivery of Behavioral Health Services.
    Humensky JL; Duffy SQ; Cubillos L; Freed MC; Rupp A
    J Ment Health Policy Econ; 2024 Mar; 27(1):33-39. PubMed ID: 38634396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sun-downing and integration for the advancement of science and therapeutics: the National Institute on Substance Use Disorders (NISUD).
    Grabowski J
    Addiction; 2010 Dec; 105(12):2044-9. PubMed ID: 20712817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blending research and practice: an evolving dissemination strategy in substance abuse.
    Michel ME; Pintello DA; Subramaniam G
    Soc Work Public Health; 2013; 28(3-4):302-12. PubMed ID: 23731421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Planning the new national institute on substance use and addiction disorders.
    Nestler EJ; Krystal JH
    Biol Psychiatry; 2012 Aug; 72(3):166-7. PubMed ID: 22683089
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental and clinical psychopharmacology: National Institute on Drug Abuse's clinical research agenda.
    Leshner AI
    Exp Clin Psychopharmacol; 2002 Aug; 10(3):159-61. PubMed ID: 12233978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Data compatibility in the addiction sciences: an examination of measure commonality.
    Conway KP; Vullo GC; Kennedy AP; Finger MS; Agrawal A; Bjork JM; Farrer LA; Hancock DB; Hussong A; Wakim P; Huggins W; Hendershot T; Nettles DS; Pratt J; Maiese D; Junkins HA; Ramos EM; Strader LC; Hamilton CM; Sher KJ
    Drug Alcohol Depend; 2014 Aug; 141():153-8. PubMed ID: 24954640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Institute on Drug Abuse (NIDA) research priorities to support the development of incentive-based treatments for substance use disorders.
    Aklin WM; Herrmann ES
    Prev Med; 2023 Nov; 176():107650. PubMed ID: 37524231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addiction research centres and the nurturing of creativity: National Drug Dependence Treatment Centre, India--a profile.
    Ray R; Dhawan A; Chopra A
    Addiction; 2013 Oct; 108(10):1705-10. PubMed ID: 23075217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National Institute on Drug Abuse International Program: improving opioid use disorder treatment through international research training.
    Gust SW; McCormally J
    Curr Opin Psychiatry; 2018 Jul; 31(4):287-293. PubMed ID: 29771745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Training the next generation of providers in addiction medicine.
    Rasyidi E; Wilkins JN; Danovitch I
    Psychiatr Clin North Am; 2012 Jun; 35(2):461-80. PubMed ID: 22640766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal models of substance abuse and addiction: implications for science, animal welfare, and society.
    Lynch WJ; Nicholson KL; Dance ME; Morgan RW; Foley PL
    Comp Med; 2010 Jun; 60(3):177-88. PubMed ID: 20579432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plan for addiction institute splits NIH.
    Wadman M
    Nature; 2010 Oct; 467(7316):643. PubMed ID: 20930813
    [No Abstract]   [Full Text] [Related]  

  • 18. A mapping review of NIDA-funded implementation research studies on treatments for opioid and/or stimulant use disorders.
    Cheng H; Chokron Garneau H; Yuan M; McGovern MP
    Drug Alcohol Depend; 2021 Aug; 225():108767. PubMed ID: 34052689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global Scientific Production on Illicit Drug Addiction: A Two-Decade Analysis.
    Khalili M; Rahimi-Movaghar A; Shadloo B; Mojtabai R; Mann K; Amin-Esmaeili M
    Eur Addict Res; 2018; 24(2):60-70. PubMed ID: 29627821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dissenting view from one who has known both NIDA and NIAAA.
    Meyer RE
    Addiction; 2010 Dec; 105(12):2051-3; discussion 2056. PubMed ID: 21105302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.